In vitro assays for COVID-19 drug development

In vitro assay

Service description

SARS-CoV-2 specific assays have been developed and are made available for the development of antiviral drugs: 

In vitro (Vero E6 cells or other models):

  • Cell viability/cytotoxicity at different time points, using cell titer Glo Cytopathic effect Assessment of the CPE and determination of EC50 Viral titration by qPCR Viral titration by PFU
  • Strains of SARS-CoV-2 available: Wuhan, South African (Bêta), Brazilian (gamma), UK (Alpha), Indian (Delta) and Omicron
  • Controls: infected and uninfected cells + remdesivir

This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the request
  • Compounds or library to test

    Further details on the project may be requested.

You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Antiviral activity testing of any type of drugs (biological or small molecule)
  • Study following the specifications validated with the Expert

Get started with your COVID-19 in vitro assay request

Please answer the fields below to be contacted by our team of scientists

section1-3
Back
home